Skip to content
Accelerator Atlas
ActiveVerifiedChecked against the program's own website or official documents.

TMC Accelerator for Cancer Therapeutics (ACT)

Biotech & Life Sciences · Run by Texas Medical Center Innovation (TMCi), funded by the Cancer Prevention and Research Institute of Texas (CPRIT) · Houston, TX

Verified Sep 28, 2026Official websiteHow to apply

Every field is checked against a primary source where we can. How we verify.

The facts

All fields verified Sep 28, 2026
Terms model
Equity-freeProvides support with no cash invested and no equity taken.
Investment
Not publishedNine-month accelerator at Texas Medical Center for Texas-based cancer therapeutics researchers and companies, funded by CPRIT through 2031. The FAQ says it is offered at no cost and does not take equity from participants; there is no cash investment. Support includes a curated mentor network and entrepreneurs-in-residence, grant-writing support, computational chemistry resources, and access to Therapeutic Labs @ TMC and vivarium facilities. Participants must complete a business grant submission (SBIR/STTR or CPRIT) by the end of the program, so they need to incorporate during it. Applications for the next cohort close October 30, 2026; the FAQ says the program commences in January, while the application form's timeline shows it running February to September 2027. This is a separate program from TMCi's HealthTech Accelerator.
Equity taken
Not publishedNine-month accelerator at Texas Medical Center for Texas-based cancer therapeutics researchers and companies, funded by CPRIT through 2031. The FAQ says it is offered at no cost and does not take equity from participants; there is no cash investment. Support includes a curated mentor network and entrepreneurs-in-residence, grant-writing support, computational chemistry resources, and access to Therapeutic Labs @ TMC and vivarium facilities. Participants must complete a business grant submission (SBIR/STTR or CPRIT) by the end of the program, so they need to incorporate during it. Applications for the next cohort close October 30, 2026; the FAQ says the program commences in January, while the application form's timeline shows it running February to September 2027. This is a separate program from TMCi's HealthTech Accelerator.
Program length
39 weeks
Format
Not published
Location
Houston, TX
Cohorts per year
1
Cohort size
24 participants (2025 cohort)
Stage focus
academic investigators and early-stage biotech companies
Sub-vertical
cancer therapeutics
Demographic focus
Not published
Backers
Cancer Prevention and Research Institute of Texas (CPRIT), Texas Medical Center
Notable alumni
Not published

Terms notes: Nine-month accelerator at Texas Medical Center for Texas-based cancer therapeutics researchers and companies, funded by CPRIT through 2031. The FAQ says it is offered at no cost and does not take equity from participants; there is no cash investment. Support includes a curated mentor network and entrepreneurs-in-residence, grant-writing support, computational chemistry resources, and access to Therapeutic Labs @ TMC and vivarium facilities. Participants must complete a business grant submission (SBIR/STTR or CPRIT) by the end of the program, so they need to incorporate during it. Applications for the next cohort close October 30, 2026; the FAQ says the program commences in January, while the application form's timeline shows it running February to September 2027. This is a separate program from TMCi's HealthTech Accelerator.

Get Biotech & Life Sciences deadline alerts

One digest a week. Deadline alerts only for verticals you pick. Unsubscribe anytime.

Terms in plain English

The Accelerator for Cancer Therapeutics is a free, nine-month program at Texas Medical Center for Texas-based teams developing cancer drugs. It takes no equity and charges nothing, because the Cancer Prevention and Research Institute of Texas funds it, but it does not invest cash either. Instead you get mentors and entrepreneurs-in-residence, computational chemistry help, lab and vivarium access, and support writing at least one non-dilutive grant application (SBIR/STTR or CPRIT).

Who this is actually for

Texas-based academic investigators and early-stage companies with a cancer therapeutics project, from target discovery through preclinical work, who want structured help building a drug development and business plan. You do not need a company to apply, but you must incorporate during the program to submit the required grant application.

TMC Accelerator for Cancer Therapeutics (ACT) application deadlines

  • Next cohort, program starting early 2027 (Texas-based teams): Applications close Oct 30, 2026.

    Verified Sep 28, 2026Source

Frequently asked questions

When is the next TMC Accelerator for Cancer Therapeutics (ACT) application deadline?
The next confirmed application window for TMC Accelerator for Cancer Therapeutics (ACT) closes Oct 30, 2026.
How much does TMC Accelerator for Cancer Therapeutics (ACT) invest?
TMC Accelerator for Cancer Therapeutics (ACT) does not publish an investment amount, so we record it as not published.
How much equity does TMC Accelerator for Cancer Therapeutics (ACT) take?
TMC Accelerator for Cancer Therapeutics (ACT) does not publish the equity it takes, so we record it as not published.
Where is TMC Accelerator for Cancer Therapeutics (ACT) located and is it in person?
TMC Accelerator for Cancer Therapeutics (ACT) is based in Houston, TX.
Is TMC Accelerator for Cancer Therapeutics (ACT) still active?
As of our last check on Sep 28, 2026, TMC Accelerator for Cancer Therapeutics (ACT) is active.

Compare this program

Put TMC Accelerator for Cancer Therapeutics (ACT) side by side with up to two others to weigh cash, equity, and timing.

Compare TMC Accelerator for Cancer Therapeutics (ACT)

More like TMC Accelerator for Cancer Therapeutics (ACT)

Sources

Everything above was checked against these, verified Sep 28, 2026.